Miki Fukutani

1PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 25, 2024
Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1-Positive NSCLC: A Phase II Trial (EAST ENERGY).

Keiju Aokage, Shohei Koyama, Shogo Kumagai

Pageof 1

Frequent Collaborators

1 joint publications

Keiju Aokage

1 joint publications

Shohei Koyama

1 joint publications

Shogo Kumagai

1 joint publications

Kotaro Nomura